The Centers for Disease Control and Prevention (CDC) has now issued a recommendation for children under 8 months old to take a new RSV .
According to the updated guidelines, the drug, developed by AstraZeneca and Sanofi, is expected to be ready in the fall and while it is not a vaccine will be added to the CDC’s childhood immunization schedule.
“We had a terribly bad RSV season last year and I’m thrilled that we have a new tool to protect our infants,” CDC director Dr. Mandy Cohen said.
From Breitbart:
The drug, to be sold under the brand name Beyfortus, is expected to cost $495 per dose, and to be covered by insurance. Panelists acknowledged that it will be a challenge at first to give the shot and for providers to be reimbursed by insurers. In May, the Food and Drug Administration approved two RSV vaccines for older adults from GlaxoSmithKline and Pfizer. In August, the FDA is expected to make a decision on approving Pfizer’s vaccine for pregnant women, with the aim of passing along protection to their newborns.
